We are monitoring the impact of COVID-19 on MEA Clostridium Botulinum Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6955
Share on
Share on

Middle East and Africa Clostridium Botulinum Market Research Report – Segmented By Product, End User, Distribution Channel & Region (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6955
Pages: 145

MEA Clostridium Botulinum Market Size (2021 to 2026)

The Middle-East and Africa Clostridium Botulinum Market size is expected to be growing at a sluggish CAGR between 2021 to 2026. 

The MEA clostridium botulinum market is primary driven by the increasing segment of the people who acquire Clostridium botulinum infection and lift to sophisticated treatment tools. Also, the technological advancements in the healthcare sector have led to the launch of various types of antitoxin and antibiotics for the treatment of botulism. 

Clostridium botulinum infections are caused by the gram-positive, rod-shaped bacteria Clostridium botulinum, which generates the very deadly botulism neurotoxin. Clostridium botulinum spreads throughout the human body, causing life-threatening neuroparalytic that can be deadly. It causes flaccid paralysis by blocking the motor nerve terminal at the myoneural junction.

The other factors, such as the growing awareness among the people about various bacteria such as Clostridium botulinum and the availability of new solutions, are expected to propel the market growth. Moreover, major companies in the region are conducting several research and development activities expected to expand the market growth. In addition, increasing investment and funding by the government and private organizations to develop healthcare infrastructure and favorable government initiatives boost market growth. 

However, the high cost of new botulism therapies and late and incorrect diagnosis of the disease is likely to limit the MEA botulism market. In addition, the botulism mark is hampered by a lack of adequate knowledge and awareness of botulism, a lack of competent healthcare infrastructure in emerging regions, and unaffordability in middle-income countries.

The botulinum toxin segment is expected to lead the global clostridium botulinum market. The growing population of aged 25 influences the market growth to 60, rising demand for minimally invasive and non-invasive procedures across the MEA. Besides that, during the forecast period, the hospital sector is expected to account for most MEA market share. The expansion of the clostridium botulinum market is aided by the availability of sophisticated healthcare infrastructure, highly qualified and trained medical personnel and growing demand for aesthetic Botox procedures. 

This research report on the MEA Clostridium Botulinum market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Botulinum Toxin Type A      
  • Botulinum Toxin Type B     

By Application:

  • Aesthetics
  • Therapeutics  

By Distribution Channel:

  • Hospitals  
  • Clinics        
  • Retail pharmacies 

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the MEA Clostridium botulism market is anticipated to grow at the fastest pace during the forecast period. The market growth in the region is attributed to the Y-O-Y rise in patient pool, increase in awareness about health, government initiatives to improve health care infrastructure, and availability of modern treatment techniques. Countries such as South Africa, Saudi Arabia, and UAE significantly contribute and expand the MEA regional market growth. Over the forecast period, the United Arab Emirates and Saudi Arabia are the most important markets in the Middle East and Africa. The market growth is propelled by advancements in the health care market and an increase in the availability of specialty care centers. Moreover, the rise in the prevalence of communicable diseases drives the botulism market.


Companies with a presence in the MEA clostridium botulinum infections market are XOMA Ltd., AlphaVax, Inc., Cangene Corporation, Morphotek, Inc., DynPort Vaccine Company LLC, Emergent BioSolutions, Inc., Molecular Targeting Technologies, Inc., and many others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Botulinum toxin type A      

                                5.1.3 Botulinum toxin type B      

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Aesthetic 

                                5.2.3 Therapeutics          

                                5.2.4 Y-o-Y Growth Analysis, By application         

                                5.2.5 Market Attractiveness Analysis, By application       

                                5.2.6 Market Share Analysis, By application         

                5.3 Distribution channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Retail pharmacies 

                                5.3.5 Y-o-Y Growth Analysis, By distribution channel       

                                5.3.6  Market Attractiveness Analysis, By distribution channel    

                                5.3.7  Market Share Analysis, By distribution channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Product

                                       By application

                                       By distribution channel

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Product

                                       By application

                                       By distribution channel

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Product

                                       By application

                                       By distribution channel

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DynPort Vaccine Company                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Emergent BioSolutions, Inc.                

                8.3 XOMA Ltd.                  

                8.4 AlphaVax                     

                8.5 Cangene Corporation                             

                8.6 Morphotek, Inc.                       

                8.7 Morphotek, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product, Type with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Clostridium Botulinum Infections Market, By Product, From 2021 to 2026 (USD Billion)
  2. Middle East and Africa Botulinum toxin type A Market, By Region, From 2021 to 2026 (USD Billion)
  3. Middle East and Africa Botulinum toxin type B Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East and Africa Clostridium Botulinum Infections Market, By Application, From 2021 to 2026 (USD Billion)
  5. Middle East and Africa Aesthetic Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East and Africa Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East and Africa Clostridium Botulinum Infections Market, By Distribution channel, From 2021 to 2026 (USD Billion)
  8. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East and Africa Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  10. Middle East and Africa Retail pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East Clostridium Botulinum Infections Market, By Product, From 2021 to 2026 (USD Billion)
  12. Middle East Clostridium Botulinum Infections Market, By Application, From 2021 to 2026 (USD Billion)
  13. Middle East Clostridium Botulinum Infections Market, By Distribution channel, From 2021 to 2026 (USD Billion)
  14. Africa Clostridium Botulinum Infections Market, By Product, From 2021 to 2026 (USD Billion)
  15. Africa Clostridium Botulinum Infections Market, By Application, From 2021 to 2026 (USD Billion)
  16. Africa Clostridium Botulinum Infections Market, By Distribution channel, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample